Regulatory News
Friday, March 25, 2016
FDA staff backs Acadia's drug to treat psychosis associated with Parkinson's disease
March 25 (Reuters) - U.S. Food and Drug Administration staff
members said on Friday Acadia Pharmaceuticals Inc's
drug to treat psychosis associated with Parkinson's disease was
effective enough to...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment